Welcome to our dedicated page for Kadant SEC filings (Ticker: KAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kadant Inc. (NYSE: KAI) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Kadant is incorporated in Delaware and lists its common stock on the New York Stock Exchange under the symbol KAI, as noted in its Form 8-K filings. Through these documents, investors can review how the company reports its financial results, describes material events, and manages its capital structure.
Regular current reports on Form 8-K furnish Kadant’s quarterly earnings press releases and investor presentation materials. In these filings, the company discusses revenue, net income, earnings per share, bookings, and cash flow, and presents non-GAAP measures such as organic revenue, adjusted net income, adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, and free cash flow. The filings explain which items are excluded from these non-GAAP metrics and why management uses them to assess underlying performance.
Other 8-K filings document material corporate actions, such as the completion of the acquisition of Clyde Industries Holdings, Inc. and amendments to Kadant’s Amended and Restated Credit Agreement. For example, one filing describes an Eighth Amendment that increased revolving loan commitments, extended the maturity of the unsecured credit facility, adjusted multicurrency and letter of credit sublimits, and added an Australian subsidiary as an authorized borrower. These disclosures help readers understand Kadant’s financing arrangements and acquisition activity.
On Stock Titan, Kadant’s filings are updated as they are made available through the EDGAR system. AI-powered summaries highlight the key points in lengthy documents, helping users quickly identify items related to earnings, credit facilities, acquisitions, and other significant developments. Investors can also use this page to trace the history of Kadant’s reported non-GAAP measures, review the terms of its credit agreements, and follow the regulatory record surrounding its strategic transactions.
Kadant Inc. director reports vesting of restricted stock units. A director of Kadant Inc. reported that on January 3, 2026, 131 shares of Kadant common stock were delivered upon partial vesting of a restricted stock unit award granted under an agreement dated May 14, 2025. Following this transaction, the director beneficially owns 8,748 shares of Kadant common stock directly and 3 shares indirectly through the director’s son. The transaction was reported on a Form 4 as a mandatory insider ownership update.
Kadant Inc. director reports vesting of restricted stock units. A company director converted a restricted stock unit award into 131 shares of Kadant common stock on January 3, 2026. The transaction was reported as a code M, meaning derivative securities were converted into common stock at an exercise price of $0.
After this partial vesting, the director now beneficially owns 3,197 shares of Kadant common stock in direct ownership. The vesting relates to a restricted stock unit award agreement dated May 14, 2025.
Kadant Inc. reported a routine insider equity transaction by one of its directors. On January 3, 2026, the director acquired 131 shares of Kadant common stock through the partial vesting of a previously granted restricted stock unit award. The transaction was reported as an acquisition of common stock following the vesting event.
After this transaction, the director beneficially owns 1,272 shares of Kadant common stock in direct form. The related restricted stock units were fully settled in shares, leaving no remaining derivative securities from this particular award.
Kadant Inc. director reports routine stock award vesting
A director of Kadant Inc. reported the vesting of a restricted stock unit award and the related issuance of common shares. On January 3, 2026, 131 restricted stock units were converted into 131 shares of Kadant common stock at an exercise price of $0, as part of a partial vesting under an award agreement dated May 14, 2025. Following this transaction, the director beneficially owns 4,513 shares of Kadant common stock held directly. This filing reflects standard equity compensation rather than an open‑market purchase or sale.
Kadant Inc. director reported a small change in ownership from restricted stock units vesting. On January 3, 2026, a restricted stock unit award partially vested, resulting in the delivery of 131 shares of common stock to the reporting person at an exercise price of $0. The award was originally granted under a restricted stock unit award agreement dated May 14, 2025. After this transaction, the director beneficially owns 7,834 shares of Kadant Inc. common stock in direct form.
Kadant Inc. director reports stock sale
A director of Kadant Inc. (KAI) reported selling 1,435 shares of common stock on 11/25/2025. The shares were sold at a weighted average price of $282.3554 per share, with actual sale prices ranging from $281.79 to $282.52. After this transaction, the director beneficially owns 3,066 shares of Kadant common stock in direct ownership. The filing notes that detailed information on the number of shares sold at each individual price within the range is available to the SEC, the company, or any security holder upon request.
Kadant Inc. (KAI) had a holder file a Form 144 to potentially sell 1,435 shares of its common stock on the NYSE, with an aggregate market value of $405,019.23.
The planned sale would be executed through Wells Fargo Clearing Services and is targeted around November 25, 2025. The filing notes that 11,778,135 shares of Kadant common stock were outstanding, providing context for the relative size of the proposed sale. The shares were acquired through multiple restricted stock vesting events between June 2022 and September 2023.
Wasatch Advisors LP has filed Amendment No. 9 to a Schedule 13G reporting its beneficial ownership in Kadant Inc. common stock. The firm reports beneficial ownership of 884,597 shares, representing 7.5% of Kadant’s outstanding common stock as of 09/30/2025. Wasatch has sole power to vote 627,115 shares and sole power to dispose of all 884,597 shares, with no shared voting or dispositive power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Kadant.
KAI filed a Form 144 notice indicating a planned sale of restricted/controlled securities by a shareholder. The filing covers 699 shares of common stock, with an aggregate market value of $186,437.12, to be sold through Wells Fargo Clearing Services on or about 11/11/2025 on the NYSE.
The shares listed for sale were acquired via restricted stock vesting from the issuer in multiple tranches: 152 shares on 09/28/2024, 151 shares on 12/28/2024, 264 shares on 06/01/2025, and 132 shares on 09/30/2025. Form 144 is a notice of proposed sale and does not itself execute a transaction; actual sales may vary based on market conditions and applicable Rule 144 requirements.
Kadant Inc. (KAI) filed a Form 4 reporting director transactions. On 11/11/2025, the reporting person sold common stock in two open‑market transactions. One sale covered 342 shares at a weighted average price of $266.5245, and another covered 357 shares at a weighted average price of $267.2766.
The filing notes price ranges for these aggregated trades: $266.1501 to $266.94 per share for the first group and $267.20 to $267.42 for the second. Following these sales, the reporting person beneficially owned 1,141 shares directly. The transaction code shown is “S.”
FAQ
What is the current stock price of Kadant (KAI)?
What is the market cap of Kadant (KAI)?
